Answer
It is licensed as long-term enzyme replacement therapy for people with a confirmed diagnosis of Fabry disease who fall within the licensed age group.
Sources for this answer
- Fabrazyme 35mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.